CN113558247A - A method for preparing tablet containing high content of milk mineral salt - Google Patents
A method for preparing tablet containing high content of milk mineral salt Download PDFInfo
- Publication number
- CN113558247A CN113558247A CN202110884156.0A CN202110884156A CN113558247A CN 113558247 A CN113558247 A CN 113558247A CN 202110884156 A CN202110884156 A CN 202110884156A CN 113558247 A CN113558247 A CN 113558247A
- Authority
- CN
- China
- Prior art keywords
- mineral salt
- milk mineral
- tablet
- milk
- high content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 57
- 235000013336 milk Nutrition 0.000 title claims abstract description 57
- 239000008267 milk Substances 0.000 title claims abstract description 57
- 210000004080 milk Anatomy 0.000 title claims abstract description 57
- 239000011707 mineral Substances 0.000 title claims abstract description 57
- 150000003839 salts Chemical class 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 59
- 102000008186 Collagen Human genes 0.000 claims abstract description 28
- 108010035532 Collagen Proteins 0.000 claims abstract description 28
- 229920001436 collagen Polymers 0.000 claims abstract description 28
- 239000004375 Dextrin Substances 0.000 claims abstract description 25
- 229920001353 Dextrin Polymers 0.000 claims abstract description 25
- 235000019425 dextrin Nutrition 0.000 claims abstract description 25
- 235000021277 colostrum Nutrition 0.000 claims abstract description 24
- 210000003022 colostrum Anatomy 0.000 claims abstract description 24
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 claims abstract description 23
- 239000008187 granular material Substances 0.000 claims abstract description 21
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000000945 filler Substances 0.000 claims abstract description 8
- 239000000853 adhesive Substances 0.000 claims abstract description 7
- 230000001070 adhesive effect Effects 0.000 claims abstract description 7
- 239000007884 disintegrant Substances 0.000 claims abstract description 6
- 239000000314 lubricant Substances 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 4
- 150000002333 glycines Chemical class 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims abstract description 3
- 238000007873 sieving Methods 0.000 claims abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 34
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 20
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 20
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 20
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 20
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 20
- 235000020712 soy bean extract Nutrition 0.000 claims description 20
- 235000019359 magnesium stearate Nutrition 0.000 claims description 17
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 16
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 16
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 16
- 229920003081 Povidone K 30 Polymers 0.000 claims description 15
- 239000000905 isomalt Substances 0.000 claims description 10
- 235000010439 isomalt Nutrition 0.000 claims description 10
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 229920003082 Povidone K 90 Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 229960001681 croscarmellose sodium Drugs 0.000 claims description 2
- 229960000913 crospovidone Drugs 0.000 claims description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- 235000013325 dietary fiber Nutrition 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 238000005469 granulation Methods 0.000 abstract description 28
- 230000003179 granulation Effects 0.000 abstract description 28
- 239000000463 material Substances 0.000 abstract description 16
- 238000002360 preparation method Methods 0.000 abstract description 15
- 239000007779 soft material Substances 0.000 abstract description 9
- 238000000576 coating method Methods 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 206010049040 Weight fluctuation Diseases 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 235000010755 mineral Nutrition 0.000 description 40
- 235000002639 sodium chloride Nutrition 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 19
- 239000002994 raw material Substances 0.000 description 11
- 238000005070 sampling Methods 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a preparation method of a tablet containing high-content milk mineral salt components, which comprises the following steps: mixing semen glycines extract, milk mineral salt, dextrin, isomaltitol, colostrum alkaline protein powder, and collagen powder uniformly, adding adhesive, granulating, drying, and sieving to obtain milk mineral salt-containing granule; mixing the milk-containing mineral salt granules, filler, disintegrant and lubricant, and tabletting to obtain tablet containing high content of milk mineral salt. The ratio of the milk mineral salt materials in the tablets prepared by the method is increased to 40-65%, and the content of calcium in each tablet is greatly increased. When the soft material is prepared, the granulation property is good, the tablet weight fluctuation is small, the hardness is stable, the phenomena of tablet breaking, edge breaking and the like do not occur in the coating process, the formability of the tablet is improved, the hardness, the friability and the disintegration time limit are improved, and the feasibility of the production process is improved.
Description
Technical Field
The invention relates to the field of health-care food or food, in particular to a preparation method of a tablet containing high-content milk mineral salt components.
Background
Tablets are one of the most widely used dosage forms. The preparation method of the tablet comprises wet granulation tabletting, dry granulation tabletting, direct powder tabletting, direct crystallization tabletting and the like. Among them, wet granulation and tableting are most commonly used. The preparation method of the tablet not only influences the physicochemical properties (such as appearance, dissolution rate, stability and the like) of the product, but also possibly influences the effect of the product after taking. Therefore, it is very important to study the preparation method of the tablet.
The health food contains more calcium-supplementing products, milk mineral salt is used as a calcium source, the content of milk mineral salt raw materials is generally 10-35% when the health food is prepared into tablets, and excipients used for granulation generally comprise mannitol, sorbitol, crystalline fructose, white granulated sugar, glucose, carboxymethyl chitosan, silicon dioxide, magnesium stearate and the like. However, when the content of the milk mineral salt is 40% or more, the granulation property is poor when the milk mineral salt is made into a soft mass by making into tablets. During tabletting, the tablet weight fluctuation is large, the hardness is unstable, the tablet is easy to break, the edge is broken and the like in the coating process, and the product is unstable at high and low time limit during disintegration.
Disclosure of Invention
In view of the above, the present invention aims to provide a method for preparing a tablet containing a high content of milk mineral salt, which can effectively solve the technical problems existing in the tabletting of the high content of milk mineral salt.
The invention is realized by the following technical scheme:
a method for preparing a tablet containing a high content of milk mineral salt ingredients, comprising the steps of:
(1) mixing semen glycines extract, milk mineral salt, dextrin, isomaltitol, colostrum alkaline protein powder, and collagen powder uniformly, adding adhesive, granulating, drying, and sieving to obtain milk mineral salt-containing granule;
(2) mixing the milk-containing mineral salt granules, filler, disintegrant and lubricant, and tabletting to obtain tablet containing high content of milk mineral salt.
Preferably, in the tablet, by mass percentage, 2-7.5% of soybean extract, 40-65% of milk mineral salt, 2-13% of dextrin, 4-11% of isomaltitol, 2-3% of colostrum basic protein powder, 5-9% of collagen powder, 9-17% of filler, 2-3% of disintegrant, 2-3% of adhesive and 0.5-1.0% of lubricant.
Preferably, the binder is one or a mixture of several of povidone K30, povidone K90, sodium carboxymethylcellulose and hydroxypropyl methylcellulose.
Preferably, the filler is one or a mixture of more of microcrystalline cellulose, isomalt, sorbitol, xylitol, calcium hydrogen phosphate, dextrin, maltodextrin or water-soluble dietary fibers.
Preferably, the disintegrating agent is one or a mixture of several of hydroxypropyl cellulose, crospovidone, croscarmellose sodium and sodium carboxymethyl starch.
Preferably, the lubricant is one or a mixture of magnesium stearate, talcum powder and silicon dioxide.
Compared with the prior art, the invention has the following beneficial effects:
according to the method, dextrin, isomaltitol, colostrum basic protein powder and collagen powder are added into milk mineral salt and soybean extract for granulation, the milk mineral salt is diluted, viscous materials are added for adsorption, various auxiliary materials are added for mixing and tabletting, the proportion of the milk mineral salt in the prepared tablet is increased to 40% -65%, and the content of calcium in each tablet is greatly increased. When the soft material is prepared, the granulation property is good, the tablet weight fluctuation is small, the hardness is stable, the phenomena of tablet breaking, edge breaking and the like do not occur in the coating process, the formability of the tablet is improved, the hardness, the friability and the disintegration time limit are improved, and the feasibility of the production process is improved.
Detailed Description
The present invention is further illustrated by the following specific embodiments, which are not intended to limit the scope of the invention.
Comparative example 1:
the raw materials are as follows by mass percent:
7.5% of soybean extract, 43.9% of milk mineral salt, 13.6% of dextrin, 3% of colostrum basic protein powder, 5.5% of collagen powder, 20% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 3% of povidone K30 aqueous solution and 0.5% of magnesium stearate.
The preparation method comprises the following steps:
putting the soybean extract, milk mineral salt, dextrin and microcrystalline cellulose into a wet granulator, and mixing until the color is uniform; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, adding colostrum basic protein powder, collagen powder and hydroxypropyl cellulose magnesium stearate, and mixing until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Comparative example 2:
the raw materials are as follows by mass percent:
7.5% of soybean extract, 43.9% of milk mineral salt, 8.6% of erythritol, 5% of crystalline fructose, 3% of colostrum basic protein powder, 5.5% of collagen powder, 20% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 3% of povidone K30 aqueous solution and 0.5% of magnesium stearate.
The preparation method comprises the following steps:
putting the soybean extract, milk mineral salt, erythritol and crystalline fructose into a wet granulator, and mixing until the color is uniform; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, colostrum basic protein powder, collagen powder, microcrystalline cellulose, hydroxypropyl cellulose and magnesium stearate are added and mixed until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Comparative example 3:
the raw materials are as follows by mass percent:
7.5% of soybean extract, 43.9% of milk mineral salt, 5% of dextrin, 11% of isomalt, 3% of colostrum basic protein powder, 5.5% of collagen powder, 17.6% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 3% of povidone K30 aqueous solution and 0.5% of magnesium stearate.
The preparation method comprises the following steps:
putting the soybean extract, milk mineral salt, dextrin and isomaltitol into a wet granulator, and mixing until the color is uniform; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, colostrum basic protein powder, collagen powder, microcrystalline cellulose, hydroxypropyl cellulose and magnesium stearate are added and mixed until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Comparative example 4:
the raw materials are as follows by mass percent:
7.5% of soybean extract, 43.9% of milk mineral salt, 5% of dextrin, 11% of isomalt, 3% of colostrum basic protein powder, 5.5% of collagen powder, 17.6% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 3% of povidone K30 aqueous solution and 0.5% of magnesium stearate.
The preparation method comprises the following steps:
putting soybean extract, milk mineral salt, dextrin, isomaltitol and 50% microcrystalline cellulose into a wet granulator, and mixing until the color is uniform; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, colostrum basic protein powder, collagen powder, 50 percent microcrystalline cellulose, hydroxypropyl cellulose and magnesium stearate are added and mixed until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Comparative example 6:
the raw materials are as follows by mass percent:
soybean extract 7.5%, milk mineral salt 43.9%, dextrin 5%, isomalt 11%, colostrum alkaline protein powder 3%, collagen powder 5.5%, microcrystalline cellulose 17.6%, hydroxypropyl cellulose 3%, polyvidone K303%, and magnesium stearate 0.5%
The preparation method comprises the following steps:
putting soybean extract, milk mineral salt, dextrin, isomaltitol, and colostrum basic protein powder into wet granulator, and mixing to obtain uniform color; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, adding collagen powder, microcrystalline cellulose, hydroxypropyl cellulose and magnesium stearate, and mixing until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Example 1:
the raw materials and the proportion are the same as those in comparative example 6.
The preparation method comprises the following steps:
putting soybean extract, milk mineral salt, dextrin, isomaltitol, colostrum basic protein powder and collagen powder into a wet granulator, and mixing until the color is uniform; transferring the material into a boiling granulator, adding povidone K30 water solution for granulation, drying until the moisture content of the granules is 3-6% and meets the requirement, and then using a 16-20 mesh sieve for granulation; after the granules are finished, microcrystalline cellulose, hydroxypropyl cellulose and magnesium stearate are added and mixed until the color is uniform; tabletting was carried out using a rotary tablet press, and sampling was carried out, the results of which are shown in Table 1.
Example 2:
the raw materials are as follows by mass percent:
5.0% of soybean extract, 50% of milk mineral salt, 5% of dextrin, 11% of isomaltitol, 2% of colostrum basic protein powder, 6.5% of collagen powder, 12.5% of microcrystalline cellulose, 2% of sodium carboxymethyl starch, 3% of povidone K30 aqueous solution and 0.8% of magnesium stearate.
The preparation method is the same as example 1, sampling detection is carried out, and the results are shown in Table 1.
Example 3:
the raw materials are as follows by mass percent:
5% of soybean extract, 60% of milk mineral salt, 4.3% of dextrin, 8.2% of isomaltitol, 2% of colostrum basic protein powder, 8% of collagen powder, 10.5% of microcrystalline cellulose, 2% of hydroxypropyl cellulose, 2% of povidone K30 aqueous solution and 1.0% of silicon dioxide.
The preparation method is the same as example 1, sampling detection is carried out, and the results are shown in Table 1.
Example 4:
the raw materials are as follows by mass percent:
2% of soybean extract, 65% of milk mineral salt, 2% of dextrin, 4.2% of isomaltitol, 2% of colostrum basic protein powder, 9% of collagen powder, 9.8% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 2% of povidone K90 aqueous solution and 1.0% of magnesium stearate.
The preparation method is the same as example 1, sampling detection is carried out, and the results are shown in Table 1.
Comparative example 5:
the raw materials are as follows by mass percent:
2% of soybean extract, 70% of milk mineral salt, 2% of dextrin, 4.2% of isomaltitol, 2% of colostrum basic protein powder, 6% of collagen powder, 8.8% of microcrystalline cellulose, 3% of hydroxypropyl cellulose, 1% of povidone K30 aqueous solution and 1.0% of magnesium stearate.
The preparation method is the same as example 2, sampling detection is carried out, and the results are shown in Table 1.
TABLE 1
As can be seen from the results in Table 1, in comparative examples 1 to 4, after the soybean extract and the milk mineral salt are directly mixed with the adhesive for size stabilization, the colostrum basic protein powder, the collagen powder and other auxiliary materials are added for mixing and tabletting, the soft material has poor granularity, more fine powder and serious floating powder, and the fine powder is more and the cloth bag is easy to block during drying. The material flowability is poor during tabletting, and the material cannot be smoothly filled into the die hole of the tabletting machine and cannot be normally tabletted.
Comparative example 2 is different from comparative example 3 mainly in the addition of auxiliary materials during the granulation, comparative example 2 is added with erythritol and crystalline fructose, and comparative example 3 is added with dextrin and isomalt, and from the results, it can be shown that the granulation property of the soft material is improved by adding dextrin and isomalt, and thus, the dextrin and isomalt are selected for the granulation of the present invention.
The comparative example 4 is different from the comparative example 3 in that microcrystalline cellulose is added in two times, and from the results, it can be seen that the flowability of the comparative example 4 is deteriorated, more fine powder is obtained after granulation, the hardness of the tablet is decreased, and the fluctuation of the tablet weight is very large, which is out of the intended purpose, as compared with the comparative example 3. Therefore, the present invention adopts a mode of adding all fillers such as microcrystalline cellulose.
In comparative example 5, the ratio of milk mineral salt was too high, the granulation of soft material was poor, the difference in sheet weight was large, and the process was uncontrollable.
The difference between comparative example 6 and example 1 is whether collagen powder is added externally, in comparative example 6, colostrum basic protein powder and milk mineral salt are granulated, and the collagen powder is added externally, although the granulation performance of the soft material is improved, the best granulation is not achieved. The milk mineral salt material is light and has strong hydrophobicity, hardly generates viscosity when meeting water or being mixed with adhesive, and has poor granulation property of soft material. The collagen powder generates larger viscosity after meeting water or being mixed with an adhesive, and has better viscosity when being mixed and granulated with the milk mineral salt material, thereby making up the defects of the milk mineral salt material. The collagen powder and the corresponding materials are granulated together, so that the soft material has good granulation property, less fine powder and uniform granules. The hardness of the plain tablets is obviously improved, the fluctuation range of tablet weight is smaller, and the quality is controllable. The coating process has no phenomena of fragment and edge breaking. Therefore, the invention first granulates the collagen powder and the milk mineral salt.
In examples 1-4, dextrin, isomalt, colostrum basic protein powder, and collagen powder were added to milk mineral salt and soybean extract for granulation, and other excipients were added for mixing and tabletting, so that the soft material had good granulation property, less fine powder, and uniform granules. The hardness of the tablet can reach 21-28 kg, the hardness is obviously improved, the friability is below 0.2%, and the disintegration time is less than or equal to 35 min. The tablet weight difference is within +/-3 percent, the fluctuation range of the tablet weight is small, the phenomena of tablet breaking and edge knocking exist in the coating process, the production operation is feasible, and the quality can be controlled.
Claims (6)
1. A method for preparing a tablet containing a high content of milk mineral salt ingredients, comprising the steps of:
(1) mixing semen glycines extract, milk mineral salt, dextrin, isomaltitol, colostrum alkaline protein powder, and collagen powder uniformly, adding adhesive, granulating, drying, and sieving to obtain milk mineral salt-containing granule;
(2) mixing the milk-containing mineral salt granules, filler, disintegrant and lubricant, and tabletting to obtain tablet containing high content of milk mineral salt.
2. The method for preparing a tablet containing a high content of milk mineral salt component according to claim 1, wherein the tablet comprises, by mass, 2-7.5% of soybean extract, 40-65% of milk mineral salt, 2-13% of dextrin, 4-11% of isomalt, 2-3% of colostrum basic protein powder, 5-9% of collagen powder, 9-17% of filler, 2-3% of disintegrant, 2-3% of binder, and 0.5-1.0% of lubricant.
3. The method for preparing a tablet containing a high content of milk mineral salt ingredients according to claim 1 or 2, wherein the binder is one or a mixed solution of several of povidone K30, povidone K90, sodium carboxymethylcellulose or hydroxypropylmethyl cellulose.
4. The method for producing a tablet containing a high content of a milk mineral salt component according to claim 1 or 2, wherein the filler is one or a mixture of several of microcrystalline cellulose, isomalt, sorbitol, xylitol, dibasic calcium phosphate, dextrin, maltodextrin or water-soluble dietary fiber.
5. The method for preparing a tablet containing a high content of milk mineral salt ingredients according to claim 1 or 2, wherein the disintegrant is one or a mixture of several of hydroxypropyl cellulose, crospovidone, croscarmellose sodium or sodium carboxymethyl starch.
6. The method of claim 1 or 2, wherein the slip is one or a mixture of magnesium stearate, talc or silica.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110884156.0A CN113558247B (en) | 2021-08-03 | 2021-08-03 | A method for preparing tablet containing high content of milk mineral salt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110884156.0A CN113558247B (en) | 2021-08-03 | 2021-08-03 | A method for preparing tablet containing high content of milk mineral salt |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113558247A true CN113558247A (en) | 2021-10-29 |
CN113558247B CN113558247B (en) | 2022-05-31 |
Family
ID=78170033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110884156.0A Active CN113558247B (en) | 2021-08-03 | 2021-08-03 | A method for preparing tablet containing high content of milk mineral salt |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113558247B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721230A (en) * | 2015-04-13 | 2015-06-24 | 福州乾正药业有限公司 | Composite of milk basic protein and milk mineral, preparation method thereof and application |
CN105687483A (en) * | 2016-03-09 | 2016-06-22 | 宁波君瑞生物科技有限公司 | Granular preparation with function of improving eyesight |
CN106720883A (en) * | 2017-02-07 | 2017-05-31 | 南京宏客泰贸易有限公司 | A kind of new candy and preparation method thereof of replenishing the calcium |
CN107969705A (en) * | 2017-11-29 | 2018-05-01 | 马艳艳 | A kind of just milk basic protein milk calcium piece and preparation method thereof |
CN108433110A (en) * | 2018-06-06 | 2018-08-24 | 广州富诺健康科技股份有限公司 | Using newborn mineral salt as the tablet and preparation method thereof of the increase bone density of raw material |
CN108576816A (en) * | 2018-03-09 | 2018-09-28 | 黑龙江飞鹤乳业有限公司 | A kind of composition increasing bone density |
CN108703249A (en) * | 2018-06-05 | 2018-10-26 | 中泰宜佳健康科技(北京)有限责任公司 | A kind of collagen product and preparation method thereof |
CN108720000A (en) * | 2018-05-10 | 2018-11-02 | 邹金林 | A kind of colostrum mineral salt calcium-supplementing preparation and preparation method thereof |
CN110279737A (en) * | 2019-07-08 | 2019-09-27 | 湖北圣峰药业有限公司 | Careless preparation of a kind of selenium-rich ginseng spirit and preparation method thereof |
CN110973635A (en) * | 2019-12-26 | 2020-04-10 | 汤臣倍健股份有限公司 | Auxiliary material composition and probiotic tablet |
CN111569052A (en) * | 2020-06-30 | 2020-08-25 | 汤臣倍健股份有限公司 | Composition for increasing bone mineral density of climacteric women and health product and application thereof |
-
2021
- 2021-08-03 CN CN202110884156.0A patent/CN113558247B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721230A (en) * | 2015-04-13 | 2015-06-24 | 福州乾正药业有限公司 | Composite of milk basic protein and milk mineral, preparation method thereof and application |
CN105687483A (en) * | 2016-03-09 | 2016-06-22 | 宁波君瑞生物科技有限公司 | Granular preparation with function of improving eyesight |
CN106720883A (en) * | 2017-02-07 | 2017-05-31 | 南京宏客泰贸易有限公司 | A kind of new candy and preparation method thereof of replenishing the calcium |
CN107969705A (en) * | 2017-11-29 | 2018-05-01 | 马艳艳 | A kind of just milk basic protein milk calcium piece and preparation method thereof |
CN108576816A (en) * | 2018-03-09 | 2018-09-28 | 黑龙江飞鹤乳业有限公司 | A kind of composition increasing bone density |
CN108720000A (en) * | 2018-05-10 | 2018-11-02 | 邹金林 | A kind of colostrum mineral salt calcium-supplementing preparation and preparation method thereof |
CN108703249A (en) * | 2018-06-05 | 2018-10-26 | 中泰宜佳健康科技(北京)有限责任公司 | A kind of collagen product and preparation method thereof |
CN108433110A (en) * | 2018-06-06 | 2018-08-24 | 广州富诺健康科技股份有限公司 | Using newborn mineral salt as the tablet and preparation method thereof of the increase bone density of raw material |
CN110279737A (en) * | 2019-07-08 | 2019-09-27 | 湖北圣峰药业有限公司 | Careless preparation of a kind of selenium-rich ginseng spirit and preparation method thereof |
CN110973635A (en) * | 2019-12-26 | 2020-04-10 | 汤臣倍健股份有限公司 | Auxiliary material composition and probiotic tablet |
CN111569052A (en) * | 2020-06-30 | 2020-08-25 | 汤臣倍健股份有限公司 | Composition for increasing bone mineral density of climacteric women and health product and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113558247B (en) | 2022-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2512455B1 (en) | Co-processed tablet excipient composition its preparation and use | |
US5137730A (en) | Tablet composition and method for problem pharmaceutical materials using citric acid | |
KR20010071883A (en) | Excipient | |
CN102058554A (en) | Method for preparing sustained-release tablets through granulating by adopting bonding agents in atomizing states | |
JPS6121526B2 (en) | ||
CA2532485A1 (en) | Tablets containing ambroxol | |
CN109512789B (en) | High-purity granular xylitol capable of being directly tabletted and preparation method thereof | |
CN113558247B (en) | A method for preparing tablet containing high content of milk mineral salt | |
CN108904455B (en) | A method for preparing tablet containing high-dose oil ester component | |
CN102077955A (en) | Soluble konjac dietary fiber tablets and preparation method thereof | |
KR101758451B1 (en) | Preparation method for rapidly dissolving tablet containing phloroglucinol anhydrous with improved stability | |
JP4774739B2 (en) | Kampo extract-containing tablet composition and method for producing the same | |
CN107281155B (en) | Azithromycin tablet and preparation method thereof | |
CN109432027B (en) | Preparation process of amoxicillin dispersible tablets | |
CN114504559B (en) | Preparation method of pharmaceutical adjuvant lactose cellulose co-processed product | |
EP3166596B1 (en) | Pharmaceutical dosage forms | |
KR101817714B1 (en) | Oral solid composite comprising valsartan | |
CN110876728A (en) | Preparation method of metformin hydrochloride quick-release preparation | |
US10420728B2 (en) | Tablet and method of preparing the same | |
CN112704666B (en) | Rupatadine fumarate tablet and preparation method thereof | |
CN105769784B (en) | A kind of oral tablet of acotiamide hydrochloride trihydrate and preparation method thereof | |
US20030119906A1 (en) | Pharmaceutical forms for the oral administration of mesna | |
CN115245494A (en) | Tablet containing Vorinopram fumarate and preparation method thereof | |
KR101509489B1 (en) | Method for preparing solid oral formulation comprising valsartan | |
KR20170081077A (en) | Methods for manufacturing polycarbophil calcium tablet formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |